prostate cancer and prostatic diseases سال:2017 - دوره:20

Fa | Ar | En


prostate cancer and prostatic diseases
سال:2017 - دوره:20 - شماره:3

A review of pomegranate in prostate cancer - صفحه:265-270 Androgen deprivation therapy for prostate cancer and dementia risk: a systematic review and meta-analysis - صفحه:259-264 Association of comorbid disease burden at diagnosis with higher tumor grade in men with non-metastatic prostate cancer - صفحه:343-347 Contemporary management of men with high-risk localized prostate cancer in the United States - صفحه:283-288 Does mpMRI improve clinical criteria in selecting men with prostate cancer for active surveillance? - صفحه:323-327 Extracellular vesicles for liquid biopsy in prostate cancer: where are we and where are we headed? - صفحه:251-258 Imaging response during therapy with radium-223 for castration-resistant prostate cancer with bone metastases—analysis of an international multicenter database - صفحه:289-293 Impact of symptomatic skeletal events on health-care resource utilization and quality of life among patients with castration-resistant prostate cancer and bone metastases - صفحه:276-282 Impact of urologists’ ownership of radiation equipment in the treatment of prostate cancer - صفحه:300-304 Long-term allopurinol use decreases the risk of prostate cancer in patients with gout: a population-based study - صفحه:328-333 Longitudinal assessment of urinary PCA3 for predicting prostate cancer grade reclassification in favorable-risk men during active surveillance - صفحه:339-342 Lutetium-177-labelled anti-prostate-specific membrane antigen antibody and ligands for the treatment of metastatic castrate-resistant prostate cancer: a systematic review and meta-analysis - صفحه:352-360 Magnetic resonance imaging targeted transperineal prostate biopsy: a local anaesthetic approach - صفحه:311-317 Multiparametric MRI/ultrasound fusion-guided biopsy decreases detection of indolent cancer in African-American men - صفحه:348-351 Patient selection for prostate focal therapy in the era of active surveillance: an International Delphi Consensus Project - صفحه:294-299 ProPSA and the Prostate Health Index as predictive markers for aggressiveness in low-risk prostate cancer—results from an international multicenter study - صفحه:271-275 Reduced prostate cancer risk with green tea and epigallocatechin 3-gallate intake among Hong Kong Chinese men - صفحه:318-322 Total and beverage-specific alcohol intake and the risk of aggressive prostate cancer: a case–control study - صفحه:305-310 Trends in the use of radiation therapy for stage IIA prostate cancer from 2004 to 2013: a retrospective analysis using the National Cancer Database - صفحه:334-338